BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 29964010)

  • 21. MUC1-C Represses the Crumbs Complex Polarity Factor CRB3 and Downregulates the Hippo Pathway.
    Alam M; Bouillez A; Tagde A; Ahmad R; Rajabi H; Maeda T; Hiraki M; Suzuki Y; Kufe D
    Mol Cancer Res; 2016 Dec; 14(12):1266-1276. PubMed ID: 27658423
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bulbine frutescens phytochemical inhibits notch signaling pathway and induces apoptosis in triple negative and luminal breast cancer cells.
    Kushwaha PP; Vardhan PS; Kapewangolo P; Shuaib M; Prajapati SK; Singh AK; Kumar S
    Life Sci; 2019 Oct; 234():116783. PubMed ID: 31442552
    [TBL] [Abstract][Full Text] [Related]  

  • 23. RASSF6 promotes p21(Cip1/Waf1)-dependent cell cycle arrest and apoptosis through activation of the JNK/SAPK pathway in clear cell renal cell carcinoma.
    Liang YY; Zheng LS; Wu YZ; Peng LX; Cao Y; Cao X; Xie P; Huang BJ; Qian CN
    Cell Cycle; 2014; 13(9):1440-9. PubMed ID: 24626183
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metformin suppresses proliferation and invasion of drug-resistant breast cancer cells by activation of the Hippo pathway.
    Liu J; Li J; Chen H; Wang R; Li P; Miao Y; Liu P
    J Cell Mol Med; 2020 May; 24(10):5786-5796. PubMed ID: 32281270
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ras-association domain family protein 6 induces apoptosis via both caspase-dependent and caspase-independent pathways.
    Ikeda M; Hirabayashi S; Fujiwara N; Mori H; Kawata A; Iida J; Bao Y; Sato Y; Iida T; Sugimura H; Hata Y
    Exp Cell Res; 2007 Apr; 313(7):1484-95. PubMed ID: 17367779
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rhizoma Amorphophalli inhibits TNBC cell proliferation, migration, invasion and metastasis through the PI3K/Akt/mTOR pathway.
    Wu C; Qiu S; Liu P; Ge Y; Gao X
    J Ethnopharmacol; 2018 Jan; 211():89-100. PubMed ID: 28962890
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ad-p53 enhances the sensitivity of triple-negative breast cancer MDA-MB-468 cells to the EGFR inhibitor gefitinib.
    Wang X; Song H; Yu Q; Liu Q; Wang L; Liu Z; Yu Z
    Oncol Rep; 2015 Feb; 33(2):526-32. PubMed ID: 25501339
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long non‑coding RNA FOXD2‑AS1 regulates the tumorigenesis and progression of breast cancer via the S100 calcium binding protein A1/Hippo signaling pathway.
    Huang P; Xue J
    Int J Mol Med; 2020 Oct; 46(4):1477-1489. PubMed ID: 32945354
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A breakdown of the Hippo pathway in gastric cancer.
    Xu ZP; Zhu JS; Zhang Q; Wang XY
    Hepatogastroenterology; 2011; 58(110-111):1611-7. PubMed ID: 21940329
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The RASSF6 tumor suppressor protein regulates apoptosis and the cell cycle via MDM2 protein and p53 protein.
    Iwasa H; Kudo T; Maimaiti S; Ikeda M; Maruyama J; Nakagawa K; Hata Y
    J Biol Chem; 2013 Oct; 288(42):30320-30329. PubMed ID: 24003224
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of PI3K/Akt/mTOR overcomes cisplatin resistance in the triple negative breast cancer cell line HCC38.
    Gohr K; Hamacher A; Engelke LH; Kassack MU
    BMC Cancer; 2017 Nov; 17(1):711. PubMed ID: 29100507
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sperm-associated antigen 9 (SPAG9) promotes the survival and tumor growth of triple-negative breast cancer cells.
    Jagadish N; Gupta N; Agarwal S; Parashar D; Sharma A; Fatima R; Topno AP; Kumar V; Suri A
    Tumour Biol; 2016 Oct; 37(10):13101-13110. PubMed ID: 27449044
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of Quinacrine on Expression of Hippo signaling Pathway Components (LATS1, LATS2, and YAP) in Human Breast Cancer Stem Cells.
    Darbankhales S; Mirfakhraie R; Ghahremani H; Asadolahi M; Saket-Kisomi K; Safakish L; Darbeheshti S; Ganjkhanlou Z; Salami S; Sirati-Sabet M
    Asian Pac J Cancer Prev; 2020 Nov; 21(11):3171-3176. PubMed ID: 33247672
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mucuna pruriens (L.) DC chemo sensitize human breast cancer cells via downregulation of prolactin-mediated JAK2/STAT5A signaling.
    Sinha S; Sharma S; Vora J; Shah H; Srivastava A; Shrivastava N
    J Ethnopharmacol; 2018 May; 217():23-35. PubMed ID: 29427634
    [TBL] [Abstract][Full Text] [Related]  

  • 35. GPER/Hippo-YAP signal is involved in Bisphenol S induced migration of triple negative breast cancer (TNBC) cells.
    Deng Q; Jiang G; Wu Y; Li J; Liang W; Chen L; Su Q; Li W; Du J; Wong CKC; Chen Z; Wang H
    J Hazard Mater; 2018 Aug; 355():1-9. PubMed ID: 29758456
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumor suppressor role of microRNA-1296 in triple-negative breast cancer.
    Phan B; Majid S; Ursu S; de Semir D; Nosrati M; Bezrookove V; Kashani-Sabet M; Dar AA
    Oncotarget; 2016 Apr; 7(15):19519-30. PubMed ID: 26799586
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Deptor enhances triple-negative breast cancer metastasis and chemoresistance through coupling to survivin expression.
    Parvani JG; Davuluri G; Wendt MK; Espinosa C; Tian M; Danielpour D; Sossey-Alaoui K; Schiemann WP
    Neoplasia; 2015 Mar; 17(3):317-28. PubMed ID: 25810016
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human homolog of Drosophila expanded, hEx, functions as a putative tumor suppressor in human cancer cell lines independently of the Hippo pathway.
    Visser-Grieve S; Hao Y; Yang X
    Oncogene; 2012 Mar; 31(9):1189-95. PubMed ID: 21785462
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inactivation of the Hippo tumour suppressor pathway by integrin-linked kinase.
    Serrano I; McDonald PC; Lock F; Muller WJ; Dedhar S
    Nat Commun; 2013; 4():2976. PubMed ID: 24356468
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Caspase-dependent and caspase-independent induction of apoptosis in breast cancer by fucoidan via the PI3K/AKT/GSK3β pathway in vivo and in vitro.
    Xue M; Ji X; Xue C; Liang H; Ge Y; He X; Zhang L; Bian K; Zhang L
    Biomed Pharmacother; 2017 Oct; 94():898-908. PubMed ID: 28810530
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.